Bryan Gillis
Keine laufenden Positionen mehr
Profil
Bryan Gillis worked as the Vice President-Manufacturing & Supply at Rubius Therapeutics, Inc. from 2018 to 2022.
He then served as the Chief Technology Officer at Finch Therapeutics Group, Inc. in 2022 to 2023.
Mr. Gillis holds an MBA from Boston University and an undergraduate degree from Eastern Nazarene College.
Ehemalige bekannte Positionen von Bryan Gillis
| Unternehmen | Position | Ende |
|---|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 |
| RUBIUS THERAPEUTICS | Corporate Officer/Principal | 01.02.2022 |
Ausbildung von Bryan Gillis
| Eastern Nazarene College | Undergraduate Degree |
| Boston University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FINCH THERAPEUTICS GROUP, INC. | Health Services |
| Private Unternehmen | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
